These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 15711722)
1. Staging in childhood lymphoma: differences between FDG-PET and CT. Hermann S; Wormanns D; Pixberg M; Hunold A; Heindel W; Jürgens H; Schober O; Franzius C Nuklearmedizin; 2005 Feb; 44(1):1-7. PubMed ID: 15711722 [TBL] [Abstract][Full Text] [Related]
2. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma. Ömür Ö; Baran Y; Oral A; Ceylan Y Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817 [TBL] [Abstract][Full Text] [Related]
3. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534 [TBL] [Abstract][Full Text] [Related]
4. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707 [TBL] [Abstract][Full Text] [Related]
5. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Pelosi E; Pregno P; Penna D; Deandreis D; Chiappella A; Limerutti G; Vitolo U; Mancini M; Bisi G; Gallo E Radiol Med; 2008 Jun; 113(4):578-90. PubMed ID: 18414808 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography for detection and staging of malignant lymphoma. Buchmann I; Moog F; Schirrmeister H; Reske SN Recent Results Cancer Res; 2000; 156():78-89. PubMed ID: 10802866 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil. Cerci JJ; Pracchia LF; Soares Junior J; Linardi Cda C; Meneghetti JC; Buccheri V Clinics (Sao Paulo); 2009; 64(6):491-8. PubMed ID: 19578651 [TBL] [Abstract][Full Text] [Related]
8. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Hernandez-Pampaloni M; Takalkar A; Yu JQ; Zhuang H; Alavi A Pediatr Radiol; 2006 Jun; 36(6):524-31. PubMed ID: 16622665 [TBL] [Abstract][Full Text] [Related]
9. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
10. Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Bangerter M; Moog F; Buchmann I; Kotzerke J; Griesshammer M; Hafner M; Elsner K; Frickhofen N; Reske SN; Bergmann L Ann Oncol; 1998 Oct; 9(10):1117-22. PubMed ID: 9834825 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma. Sasaki M; Kuwabara Y; Koga H; Nakagawa M; Chen T; Kaneko K; Hayashi K; Nakamura K; Masuda K Ann Nucl Med; 2002 Jul; 16(5):337-45. PubMed ID: 12230093 [TBL] [Abstract][Full Text] [Related]
12. Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. Cheng G; Chen W; Chamroonrat W; Torigian DA; Zhuang H; Alavi A Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1469-76. PubMed ID: 21505896 [TBL] [Abstract][Full Text] [Related]
13. Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography. Hwang K; Park CH; Kim HC; Kim H; Yoon S; Pai M; Kim S Clin Nucl Med; 2000 Oct; 25(10):789-95. PubMed ID: 11043718 [TBL] [Abstract][Full Text] [Related]
14. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including Latifoltojar A; Punwani S; Lopes A; Humphries PD; Klusmann M; Menezes LJ; Daw S; Shankar A; Neriman D; Fitzke H; Clifton-Hadley L; Smith P; Taylor SA Eur Radiol; 2019 Jan; 29(1):202-212. PubMed ID: 29948084 [TBL] [Abstract][Full Text] [Related]
15. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma. Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235 [TBL] [Abstract][Full Text] [Related]
17. Extranodal malignant lymphoma: detection with FDG PET versus CT. Moog F; Bangerter M; Diederichs CG; Guhlmann A; Merkle E; Frickhofen N; Reske SN Radiology; 1998 Feb; 206(2):475-81. PubMed ID: 9457202 [TBL] [Abstract][Full Text] [Related]
18. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management. Montravers F; McNamara D; Landman-Parker J; Grahek D; Kerrou K; Younsi N; Wioland M; Leverger G; Talbot JN Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1155-65. PubMed ID: 12192560 [TBL] [Abstract][Full Text] [Related]
19. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison]. Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362 [TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. Lopci E; Burnelli R; Ambrosini V; Nanni C; Castellucci P; Biassoni L; Rubello D; Fanti S Cancer Biother Radiopharm; 2008 Dec; 23(6):681-90. PubMed ID: 19111053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]